Replimune Group, Inc. (REPL)
8.41
+0.80
(+10.51%)
USD |
NASDAQ |
Apr 02, 16:00
8.42
+0.01
(+0.12%)
After-Hours: 20:00
Replimune Group Market Cap : 766.53M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.626B |
| Phathom Pharmaceuticals, Inc. | 909.22M |
| REGENXBIO, Inc. | 435.16M |
| Corcept Therapeutics, Inc. | 4.573B |
| Catalyst Pharmaceuticals, Inc. | 2.997B |
Market Cap Related Metrics
| PEG Ratio | -0.1857 |
| Price to Book Value | 3.641 |
| Price | 8.41 |
| Earnings Yield | -38.59% |
| PEGY Ratio | -0.1857 |